As a further validation of the MS data, the overexpression of PRDX-6 in DS was also confirmed by WB analysis (+18%; p = 0.03) and support the induction of antioxidant responses to counteract OS in DS PBMCs (Figure 4E). This evidence concerns the gene PRDX6 and Dravet syndrome.